EGFR and neoplasm: Specifically, it inhibits proliferation, adhesion, invasion, and metastasis in various tumor cells by modulating signaling pathways such as JNK, HIF-1α, PI3K/Akt, Nrf2, Wnt, JAK2-STAT3, and EGFR.